Highlight BD-Focused Sessions at BIOCHINA 2026
18 December 2025
From Q1–Q3 2025, China-originated pharma license-out deals reached USD 92.03 billion, up 77% YoY, with upfront payments of USD 4.55 billion.
Leading multinational pharma sourced 20% of global in-licensing deals from China, accounting for 39% of total deal value. Nearly 40% of global payments flowed to Chinese innovators.
As BD strategy drives cross-border innovation and growth, where will global BD leaders be at BIOCHINA 2026?
1. BIOCHINA 2026 Main Forum
Strategic Insights from Global Pharma Leaders
09:00–11:00 | MNC Strategy Release
11:00–12:00 | Co-Creating a Collaborative Ecosystem with Global Partners
Speakers:
Faisal Darwazeh, Vice President, Group Business Development & Alliances, Hikma Pharmaceuticals
Albert Ren, Vice President, Worldwide Business Development China, Pfizer
Ryan Wang, Vice President, China Innovation & Partnerships, Eli Lilly
2. BIOCHINA 2026 BioBD Forum
Date: March 12, 2026
12:00–12:20 | Presentation: Insights on BD Deals for Chinese Innovative Drugs and Global Enablement
12:20–13:10 | Presentation: MNC Asia-Pacific Strategy
13:10–14:00 | Presentation: Global Strategies of Chinese Big Pharma and Biotech
15:00–16:00 | Presentation: NewCo Evolution and MNC–China Collaboration
16:00–17:00 | Presentation: Global Expansion: China’s Innovation Pathways
17:00–18:00 | Presentation: Breaking Through Payment Barriers for Innovative Drugs
Speakers:
Jean-Baptiste Duval, Director, Healthcare and Life Sciences, the cfi group
Yulan Feng, General Manager, Business Development, Fosun Pharma
Mingji Chen, Chairman and Chief Executive Officer, Biosion Biotech
Tongtong Xue, Chief Executive Officer, MediLink Therapeutics
Hua Jiang, Chairwoman and Chief Executive Officer, Boan Biotech
Jiang Zhang, Founder and Chief Executive Officer, LongRiver Investments
Download Agenda https://static.biocn.cn/file/BIOCHINA2026_Agenda_1209.pdf
To join the forum as a speaker, contact biochina@enmore.com
3. BiOPartnering2026 High-Quality Networking at BIOCHINA
Connect with global pharma leaders, explore collaboration opportunities, and meet potential partners in focused 30-minute 1V1 meetings. Engage with innovative companies and accelerate your business growth.
Early Bird Register (Ends Dec 31) https://u.morebio.cn/mABz6jLG
For promo code registration, please contact biochina@enmore.com